Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 2/20 | 0.41 |
| ▸ | PLA2G2A | P14555 | 4/20 | 0.37 |
| ▸ | PLA2G4A | P47712 | 4/20 | 0.37 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.37 |
| ▸ | PRKDC | P78527 | 6/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.35 |
| ▸ | PIM1 | P11309 | 2/20 | 0.35 |
| ▸ | CSNK2A2 | P19784 | 2/20 | 0.35 |
| ▸ | CSNK2B | P67870 | 2/20 | 0.35 |
| ▸ | PIM3 | Q86V86 | 2/20 | 0.35 |
| ▸ | PIM2 | Q9P1W9 | 1/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.34 |
| ▸ | PIK3CD | O00329 | 2/20 | 0.34 |
| ▸ | PIK3CA | P42336 | 2/20 | 0.34 |
| ▸ | PIK3CB | P42338 | 2/20 | 0.34 |
| ▸ | PIK3CG | P48736 | 2/20 | 0.34 |
| ▸ | BRD4 | O60885 | 2/20 | 0.34 |
| ▸ | BRD2 | P25440 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17057192 | 0.94 | ALOX5 (0.46) | ALOX5PLA2G2APLA2G4APLA2G10PRKDC | |
| SCHEMBL17166693 | 0.94 | ALOX5 (0.43) | ALOX5PLA2G2APLA2G4APLA2G10PRKDC | |
| SCHEMBL20097818 | 0.93 | ALOX5 (0.43) | ALOX5PLA2G2APLA2G4APLA2G10PRKDC | |
| SCHEMBL18265970 | 0.93 | ALOX5 (0.43) | ALOX5PLA2G2APLA2G4APLA2G10PRKDC | |
| SCHEMBL17228745 | 0.93 | ALOX5 (0.44) | ALOX5PLA2G2APLA2G4APLA2G10PRKDC | |
| SCHEMBL14733816 | 0.92 | ALOX5 (0.40) | ALOX5PLA2G2APLA2G4APLA2G10PRKDC | |
| SCHEMBL16573892 | 0.92 | ALOX5 (0.50) | ALOX5PLA2G2APLA2G4APLA2G10PRKDC | |
| SCHEMBL23505132 | 0.92 | ALOX5 (0.44) | ALOX5PRKDCKDM4EPIM1CSNK2A2 | |
| SCHEMBL18266066 | 0.91 | ALOX5 (0.47) | ALOX5PLA2G2APLA2G4APLA2G10PRKDC | |
| SCHEMBL2628388 | 0.91 | ALOX5 (0.44) | ALOX5PLA2G2APLA2G4APLA2G10PRKDC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9837625-B2 | Organic electroluminescent element | Konica Minolta, Inc. (JP) | 2017-12-05 | — | — | US | disclosed |
| US-9837625-B2 | Organic electroluminescent element | Konica Minolta, Inc. (JP) | 2017-12-05 | — | — | US | disclosed |
| US-9780322-B2 | Organic electroluminescent element | Konica Minolta, Inc. (JP) | 2017-10-03 | — | — | US | disclosed |
| US-9780322-B2 | Organic electroluminescent element | Konica Minolta, Inc. (JP) | 2017-10-03 | — | — | US | disclosed |
| US-9260658-B2 | Organic electroluminescence element, lighting device and display device | Konica Minolta, Inc. (JP) | 2016-02-16 | — | — | US | disclosed |
| US-9260658-B2 | Organic electroluminescence element, lighting device and display device | Konica Minolta, Inc. (JP) | 2016-02-16 | — | — | US | disclosed |
| US-20150053949-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT | Konica Minolta, Inc. (JP) | 2015-02-26 | — | — | US | disclosed |
| US-20150053949-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT | Konica Minolta, Inc. (JP) | 2015-02-26 | — | — | US | disclosed |
| US-20140339529-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT | Konica Minolta, Inc. (JP) | 2014-11-20 | — | — | US | disclosed |
| US-20140296476-A1 | PRODRUGS AND DRUG-MACROMOLECULE CONJUGATES HAVING CONTROLLED DRUG RELEASE RATES | PROLYNX LLC | 2014-10-02 | — | — | US | disclosed |
| US-20130049576-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT, LIGHTING DEVICE AND DISPLAY DEVICE | KONICA MINOLTA HOLDINGS, INC. (JP) | 2013-02-28 | — | — | US | disclosed |
| US-20130049576-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT, LIGHTING DEVICE AND DISPLAY DEVICE | KONICA MINOLTA HOLDINGS, INC. (JP) | 2013-02-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140296476-A1 | PRODRUGS AND DRUG-MACROMOLECULE CONJUGATES HAVING CONTROLLED DRUG RELEASE RATES | ABCB1, ABCB11, DNPEP | ALOX5 2572/4885PLA2G2A 2000/4885PLA2G4A 1692/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.